Category Archives: Medtronic Infuse

Featured Stories

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Medtronic Seeks Reconsideration of Infuse Ruling

medtronic_seeking_reconsideration

Device maker, Medtronic, just asked a federal judge to reconsider a ruling in a lawsuit involving its bone growth protein product, Infuse. Medtronic asked Judge G. Murray Snow, U.S. District Court for Arizona, to dismiss the lawsuit on the grounds … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

Medtronic’s InFuse Sales Soft for Second Quarter Over Safety Issues

medtronic_sales_drop

Revenues for the bone graft product, InFuse, were down for the second quarter, due to ongoing safety issues. Medtronic’s InFuse, has long been steeped in controversy, including a Senate probe, a warning issued by a federal regulator, accusations that Medtronic … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Cincinnati Spine Surgeon Facing Fraud Charges Over InFuse

spine_surgeon_fraud

A Cincinnati spine surgeon has been charged with millions of dollars in fraudulent billing for unnecessary operations using Medtronic’s bone-growth product Infuse. Dr. Abubakar Atiq Durrani, who has a private practice with offices in Evendale and Florence, Kentucky called Center … Continue reading

Posted in Medtronic Infuse |

Industry Promises Increased Transparency, Medtronic InFuse Debacle Cited

drug_company_transparency

Some of the world’s largest drug makers have promised to release detailed information about their pharmaceutical products, such as Medtronic’s InFuse, to external researchers. While many are happy with the move, others point out that this might be a way … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic’s Motion to Dismiss InFuse Lawsuit Denied

infuse_lawsuit_goes_through

An Illinois state court judge just denied device maker, Medtronic Inc.’s, bid to dismiss a lawsuit brought over its InFuse bone graft product. The lawsuit included allegations that InFuse caused a patient to undergo additional surgery that led to permanent … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Pending Sunshine Act to Focus on Allegedly Fraudulent Financial Ties Between Physicians and Industry

sunshine_act_physicians

On August 1, the Physician Payment Sunshine Act provision of the Affordable Care Act will go into effect. The Act is meant to highlight allegedly bogus relationships between physicians and pharmaceutical firms and medical device manufacturers. As we’ve long stressed, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Increased Transparency in Medicine Coming

medical_research_changes

When approved by the U.S Food and Drug Administration in 2002, Medtronic’s bone graft product, InFuse, was seen as a medical breakthrough. InFuse eliminated the need to remove patient bone from the hip in spinal fusions and could, instead, use … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Injured InFuse Users Working Toward Their Day in Court

medtronic_infuse_victims

Hundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach. The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Do Consumers Know the Risks of Medtronic InFuse? Are Consumers Aware of Safer Options?

medtronic_infuse_danger_alternatives

Medtronic’s bone graft product, InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) that was approved by the U.S. Food & Drug Administration (FDA) in 2002 for specific uses. Meant to stimulate spine growth in patients … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic Shareholders File Lawsuit Amid InFuse® Scandal

medtronic_shareholders_lawsuit

  Device maker, Medtronic, is the focus of another shareholder lawsuit over its InFuse® bone growth product. Shareholders filed the lawsuit against Medtronic and some of its shareholders accusing them of intentionally minimizing potential dangers associated with InFuse® so that … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.